Nuvation Bio Inc. — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2021-03-09

Reporting Person: Hung David (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-09	Stock Option (Right to Buy)	$12.66	A	165465	Acquired	2031-03-08	Common Stock (165465)	Direct
2021-03-09	Stock Option (Right to Buy)	$12.66	A	224760	Acquired	2031-03-08	Common Stock (224760)	Direct

Footnotes

F1: Option vests as to 25% on the one year anniversary of 3/9/2021, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

F2: Option vests upon the achievement of certain performance goals, including market-price goals, through the fifth anniversary of March 9, 2021, subject to Reporting Person's continuous service on each such vesting date.